Literature DB >> 19502077

The pattern and prevalence of lymphatic spread in thoracic oesophageal squamous cell carcinoma.

Junqiang Chen1, Suoyan Liu, Jianji Pan, Xiongwei Zheng, Kunshou Zhu, Ji Zhu, Jinrong Xiao, Mingang Ying.   

Abstract

BACKGROUND: Oesophageal squamous cell carcinoma (SCC) is a common type of cancer in China. The knowledge of its pattern of lymphatic metastasis would be of clinical value for surgical and radiation oncologists to treat this disease.
MATERIAL AND METHODS: A large series of 1850 thoracic oesophageal SCC was retrospectively analysed after extended oesophagectomy with three-field lymphadenectomy (3FL). Specimens were assessed for pattern of lymphatic spread. RESULT: Of the 1850 patients, 1081 (58.4%) developed mediastinal, cervical and/or abdominal node metastases. The lymphatic metastasis rates were 35.6%, 22.2%, 26.5%, 6.1% and 26.5%, respectively, for the cervical, upper, middle, lower mediastinal nodes and abdominal nodes. The adjacent mediastinal node metastasis alone occurred in 5.5% of patients, and the multiple level or skip node spread accounted for 20.9% and 73.6% of patients with node metastases. Upward lymphatic spread developed in 46.4% of patients, both up- and downward in 33.2%, and the downward, 20.5%. For the upper oesophageal SCC, the most common node metastasis was in the cervical (49.5%) and followed by the upper mediastinal (28.7%), middle mediastinal (11.4%), abdominal (8.0%) and lower mediastinal (1.4%) nodes. For the middle oesophageal SCC, the highest incidence of node spread was also in the cervical (35.0%) and similar rates in the middle mediastinal (29.8%), abdominal (27.2%) and upper mediastinal (22.4%) nodes, but the least in the lower mediastinal (6.0%) node. For the lower oesophageal SCC, more node metastasis occurred in the abdominal (51.7%), and followed by the middle mediastinal (25.6%), cervical (17.2%), lower mediastinal (13.9%) and upper mediastinal (10.0%). However, the lymphatic metastasis rates of the upper, middle and lower thoracic oesophageal SCC were similar. The unfavourable factors for lymphatic metastasis were long oesophageal lesion (p<0.000), late T stage (p<0.000) and poor differentiation of tumour cells (p<0.000).
CONCLUSION: The prevalence was: (1) lymphatic spread prone to the upward in the upper oesophageal SCC, downward in the lower one and both up- and downward in the middle one with in favour of the upward and (2) multiple level and skip node metastases were very often seen. The unfavourable factors for node spread were long oesophageal lesion, late T stage and poor differentiation of tumour cells.

Entities:  

Mesh:

Year:  2009        PMID: 19502077     DOI: 10.1016/j.ejcts.2009.03.056

Source DB:  PubMed          Journal:  Eur J Cardiothorac Surg        ISSN: 1010-7940            Impact factor:   4.191


  38 in total

1.  Intensity-modulated radiotherapy combined with paclitaxel and platinum treatment regimens in locally advanced esophageal squamous cell carcinoma.

Authors:  J Chen; T Su; Y Lin; B Wang; J Li; J Pan; C Chen
Journal:  Clin Transl Oncol       Date:  2017-08-04       Impact factor: 3.405

2.  A meta-analysis of lymph node metastasis rate for patients with thoracic oesophageal cancer and its implication in delineation of clinical target volume for radiation therapy.

Authors:  X Ding; J Zhang; B Li; Z Wang; W Huang; T Zhou; Y Wei; H Li
Journal:  Br J Radiol       Date:  2012-06-14       Impact factor: 3.039

3.  Precise delineation of clinical target volume for crossing-segments thoracic esophageal squamous cell carcinoma based on the pattern of lymph node metastases.

Authors:  Yuanli Dong; Hui Guan; Wei Huang; Zicheng Zhang; Dongbo Zhao; Yang Liu; Tao Zhou; Baosheng Li
Journal:  J Thorac Dis       Date:  2015-12       Impact factor: 2.895

4.  Computed tomography-based distribution of involved lymph nodes in patients with upper esophageal cancer.

Authors:  M Li; Y Liu; L Xu; Y Huang; W Li; J Yu; L Kong
Journal:  Curr Oncol       Date:  2015-06       Impact factor: 3.677

5.  Pattern of lymph node metastasis in thoracic esophageal squamous cell carcinoma with poor differentiation.

Authors:  Jinling Zhang; Yuanyuan Liu; Fengyuan Che; Yi Luo; Wei Huang; Xueyuan Heng; Baosheng Li
Journal:  Mol Clin Oncol       Date:  2018-04-13

Review 6.  The extent of lymphadenectomy in esophageal resection for cancer should be standardized.

Authors:  Eliza R C Hagens; Mark I van Berge Henegouwen; Miguel A Cuesta; Suzanne S Gisbertz
Journal:  J Thorac Dis       Date:  2017-07       Impact factor: 2.895

7.  Radiation dose to the lymph drainage area in esophageal cancer with involved-field irradiation.

Authors:  Wenbin Shen; Hongmei Gao; Shuchai Zhu; Youmei Li; Juan Li; Zhikun Liu; Jinwei Su
Journal:  Oncol Lett       Date:  2015-11-23       Impact factor: 2.967

8.  Prognostic factors in patients with thoracic esophageal carcinoma staged pT1-4aN0M0 undergone esophagectomy with three-field lymphadenectomy.

Authors:  Xiaohui Chen; Junqiang Chen; Xiongwei Zheng; Yuanmei Chen; Yu Lin; Qingfeng Zheng; Kunshou Zhu; Jianji Pan
Journal:  Ann Transl Med       Date:  2015-11

9.  A retrospective study of pattern of recurrence after radical surgery for thoracic esophageal carcinoma with or without postoperative radiotherapy.

Authors:  Yichun Wang; Li Zhang; Dongmei Ye; Wanli Xia; Jun Jiang; Xiumei Wang; Mingxia Zhang; Fan Wang
Journal:  Oncol Lett       Date:  2018-01-16       Impact factor: 2.967

10.  Factors influencing the risk of recurrence in patients with esophageal carcinoma treated with surgery: A single institution analysis consisting of 1002 cases.

Authors:  Yaping Xu; Qixun Chen; Xinmin Yu; Ximing Zhou; Xiao Zheng; Weimin Mao
Journal:  Oncol Lett       Date:  2012-10-30       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.